• 115 – Labeling Changes & Post-Market Commitments (S8E10)

  • May 4 2025
  • Duración: 16 m
  • Podcast

115 – Labeling Changes & Post-Market Commitments (S8E10)

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • This episode explores how drug labels evolve after a medication has been approved, including safety updates, new indications, and the addition of black box warnings. We discuss the regulatory commitments that companies must meet, such as post-market studies and REMS (Risk Evaluation and Mitigation Strategies) requirements. Examples of communicating with healthcare professionals and examples are shared.

    The conversation highlights communication strategies for informing healthcare providers and patients about these label changes. Real-world examples, such as label changes for opioids, biologics, and high-risk drugs, are used to illustrate the practical implications of these updates. The episode emphasizes the dynamic nature of drug labeling and the continuous process of ensuring that it reflects the most up-to-date safety and efficacy information.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre 115 – Labeling Changes & Post-Market Commitments (S8E10)

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles